FBP1は老朽化したMASH肝細胞からの肝がんの進化を制御する
Li Gu1,2,3, Yahui Zhu4,5, Shuvro P Nandi6,7,8
1Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, School of Medicine, University of California San Diego (UCSD), La Jolla, CA, USA. ligu@scu.edu.cn.
Nature
|January 1, 2025
まとめ
メタボリック機能障害に関連するステアトヘパチス (MASH) は肝がん (HCC) を引き起こす可能性があります. 研究者らは,フルークトーゼ-1,6-二酸化塩素1 (FBP1) の減少が,細胞増殖とDNA変異を促進することによって,HCCの進行を可能にすることを発見しました.
科学分野:
- ヘパトロジー
- 腫瘍学
- 分子生物学
背景:
- 肝細胞癌 (HCC) は,ウイルスによる肝損傷または代謝機能障害に関連したステア肝炎 (MASH) から生じる.
- MASHは腫瘍抑制反応である肝細胞衰老を誘発するが,この反応をバイパスしてHCCを促進するメカニズムは不明である.
- 衰老はDNAの損傷と関連しており,HCCの発達におけるその役割を理解することは極めて重要です.
研究 の 目的:
- MASH誘発のHCCにおいて,腫瘍抑制性老化反応がどのように回避されるかを明らかにする.
- MASHからHCCへの移行に関与する重要な分子プレーヤーを特定する.
- HCCの病原性におけるフルクトース-1,6-二酸化塩素1 (FBP1) の役割を理解する.
主な方法:
- FBP1をp53の標的遺伝子として識別する.
- 衰老したMASH肝細胞のFBP1発現とヒトHCCの分析
- FBP1とp53の分解を調節するAKTとNRF2の役割の調査.
- マウスモデルとヒトサンプルでの研究で 結論を検証した.
主要な成果:
- FBP1は老化中のMASH肝細胞で上昇するが,プロモーターの甲基化とタンパク質分解によってほとんどのヒトHCCで抑制される.
- 癌前肝細胞とHCC前駆細胞のFBP1濃度が低下し,AKTとNRF2の活性化に一致する.
- AKTとNRF2はFBP1とp53の分解を加速し,老化したHCCのプロリファレーションと代謝活動を促進する.
- NRF2,FBP1,AKT,およびp53を含む老化を逆転させる代謝スイッチは,MASHからHCCへの進行のためのDNA損傷の蓄積を容易にする.
結論:
- AKTとNRF2によって引き起こされるFBP1の減少は,老化を回避し,MASHからHCCの発生を可能にするために重要なステップです.
- このNRF2- FBP1- AKT- p53代謝経路は,肝がんの進行に必要な突然変異の蓄積を促進します.
- この経路をターゲットにすることで,MASHに関連したHCCの新たな治療戦略が提供される可能性があります.
関連する概念動画
Liver Regeneration
3.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.2K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Cell Specific Gene Expression
13.4K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.4K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K


